Medical College of Wisconsin studying cancer disparities

MILWAUKEE — The Medical College of Wisconsin is looking for ways to fight racial disparity in cancer deaths in the state.Black residents in Wisconsin get cancer at a 22 percent higher rate than do white residents, according to the National Cancer Institute.Factors leading to cancer disparities for African Americans include stress, income, lifestyle and poor diet.

Man battling aggressive cancer gets final wish of one last motorcycle ride

KANSAS CITY, Mo. - At 57 years old, Craig Brunner says many of his favorite memories took place on his bike."I just miss being on the motorcycle, miss our trips, miss that open air," his wife, Diane Brunner, told WDAF.After being diagnosed with an aggressive cancer, he was forced to stay off his motorcycle.

DNA-matched cancer treatment could increase survival rates as much as 6-fold

HOUSTON, Texas -- A new way of treating cancer that involves individual DNA sequencing could change survival rates, according to a new study.Researchers at the University of Texas' MD Anderson Cancer Center said they think individually matching your cancer treatment to a DNA sequencing, rather than the location of the cancer, could not only change the treatment type chosen, but it could also lead to a survival rate of that increases as much as six-fold.The study was presented at the American Society of Clinical Oncology.The results are being hailed as the biggest cancer breakthrough since chemotherapy.New treatments involve the individual analysis of DNA from a tumor that would let doctors individualize the particular cancer treatment because of the cancer's DNA, rather than commonly relying on the treatment based on the site location of the cancer, such as breast cancer, prostate cancer or lung cancer.One University of Texas researcher, Apostolia Maria Tsimberidou, said this "next-generation" sequencing should become a common method to fight cancer.CLICK HERE to view this study.

Many breast cancer patients can skip chemo, big study finds

CHICAGO — Most women with the most common form of early-stage breast cancer can safely skip chemotherapy without hurting their chances of beating the disease, doctors are reporting from a landmark study that used genetic testing to gauge each patient's risk.The study is the largest ever done of breast cancer treatment, and the results are expected to spare up to 70,000 patients a year in the United States and many more elsewhere the ordeal and expense of these drugs."The impact is tremendous," said the study leader, Dr.

Shorter drug treatment OK for many breast cancer patients

Many women with a common and aggressive form of breast cancer that is treated with Herceptin can get by with six months of the drug instead of the usual 12, greatly reducing the risk of heart damage it sometimes can cause, a study suggests.It's good news, but it comes nearly two decades after the drug first went on the market and many patients have suffered that side effect.The study was done in the United Kingdom and funded by UK government grants.